What is Theravance Biopharma's compensation and benefits?

Theravance Biopharma (TBPH) reported compensation and benefits of $8.73M in Q1 2026.

How has Theravance Biopharma's compensation and benefits changed year-over-year?

Theravance Biopharma's compensation and benefits increased by 62.1% year-over-year, from $5.39M to $8.73M.

What is the long-term trend for Theravance Biopharma's compensation and benefits?

Over 5 years (2020 to 2025), Theravance Biopharma's compensation and benefits has grown at a -18.6% compound annual growth rate (CAGR), from $35.24M to $12.59M.

Theravance Biopharma TBPH Compensation and benefits

Compensation and benefits at other companies

Aurinia PharmaceuticalsAUPH

——

PrecigenPGEN

——

Mirum Pharmaceuticals, Inc.MIRM

——

BridgeBio PharmaBBIO

——

Innoviva, Inc.INVA

——

Roivant SciencesROIV

——

Other financials

Income statement

See full

Revenue$17.7M+15.0%

Operating income-$9.5M+34.3%

Net income-$4.9M+63.7%

EPS (diluted)-$0.10+63.0%

Balance sheet

See full

Cash & equivalents$288.1M+160%

Total debt$40.5M-15.9%

Total equity$290.6M+75.1%

Total assets$472.3M+37.5%

Cash flow

See full

Operating cash flow$73.3M+70.3%

CapEx$8.0K-95.8%

Free cash flow$59.6M+5,560%

Valuation

See full

Market cap$896.51M+68.7%

Enterprise value$648.91M+38.3%

P/E7.8×—

P/S8.2×0.0×

Profitability

See full

Gross margin60.8%—

Operating margin1.2%+0.6pp

Net margin104.3%+71.4pp

FCF margin221.9%+206pp

Returns & leverage

See full

Return on equity50.2%+36.2pp

Debt / equity0.1×-0.2×

Current ratio13.1×+8.4×

Where this comes from

Reported directly by Theravance Biopharma in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Theravance Biopharma's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Theravance Biopharma's compensation and benefits?: Theravance Biopharma (TBPH) reported compensation and benefits of $8.73M in Q1 2026.
How has Theravance Biopharma's compensation and benefits changed year-over-year?: Theravance Biopharma's compensation and benefits increased by 62.1% year-over-year, from $5.39M to $8.73M.
What is the long-term trend for Theravance Biopharma's compensation and benefits?: Over 5 years (2020 to 2025), Theravance Biopharma's compensation and benefits has grown at a -18.6% compound annual growth rate (CAGR), from $35.24M to $12.59M.